$IDRA Headlines Six stocks to watch 4:27 p.m. Feb. 26,

New Post Public Reply Private Reply Replies (0) Message Board

Mar 18, 2014 at 10:26 AM

$IDRA Headlines

Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
Bears chip away at the S&P 1,775 support 12:01 p.m. Feb. 3, 2014 - Michael Ashbaugh
Charting a bullish early-2014 outlook 1:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 12:39 p.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 3:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 2:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 3:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 9:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 10:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 10:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 8:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 8:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 8:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 7:03 p.m. Feb. 28, 2007 - Michael Baron
Idera Pharma started at buy at Merriman Curhan Ford 9:54 a.m. Feb. 7, 2007 - Tomi Kilgore
Drug stocks slip; Nuvelo, Neopharm shares plunge on trial results 5:37 p.m. Dec. 11, 2006 - Carolyn Pritchard

Idera: A Compelling Biotech Pick For March 11:34 a.m. March 7, 2014 - Seeking Alpha
3 Small Cap Biotechs With Near-Term Catalysts 10:25 a.m. March 6, 2014 - Seeking Alpha
Interesting IDRA Put And Call Options For April 19th 12:01 p.m. Feb. 26, 2014 - TheStreet.com
Idera Pharmaceuticals (IDRA) Showing Signs Of Perilous Reversal Today 10:53 a.m. Feb. 24, 2014 - TheStreet.com
Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 10:38 a.m. Jan. 31, 2014 - Seeking Alpha
Idera Pharmaceuticals Presents a Promising Opportunity 3:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 8:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 7:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 8:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 9:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 9:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 2:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
Idera Enters Agreement with NCI to Evaluate Use of TLR Antagonists for Treatment of Genetically Defined Lymphomas 7:39 a.m. Aug. 29, 2013 - benzinga.com
Idera Announces Issuance of US Patent Covering IMO-8400, Lead Candidate in Phase 2 Trial 7:05 a.m. July 18, 2013 - benzinga.com
Idera Pharma to Issue Positive Phase I Trial Results on TLR Antagonist IMO-8400 6:31 a.m. June 21, 2013 - benzinga.com
Idera Pharmaceuticals Announces Initiation of a Phase 2 Trial of IMO-8400 in Patients with Moderate to Severe Plaque Psoriasis 7:07 a.m. June 5, 2013 - benzinga.com
10-Q: IDERA PHARMACEUTICALS, INC. 7:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Idera Pharmaceuticals Announces Closing of Common Share Offering 3:19 p.m. May 7, 2013 - benzinga.com
Idera Pharmaceuticals Prices 17.5M Share Offering at $0.50/Share 4:59 a.m. May 2, 2013 - benzinga.com
1 Stock to Buy, 1 Stock to Short: Penny Stocks 9:52 a.m. April 16, 2013 - InvestorPlace.com

Idera Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial Results and Provides Corporate Update 7:51 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Expansion of Pipeline into Two Orphan Autoimmune Diseases 7:35 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Appointment of Julian Baker and Dr. Kelvin Neu to its Board of Directors 8:31 a.m. March 12, 2014 - BusinessWire - BZX
Idera to Host Conference Call and Webcast to Report Fourth Quarter and Full Year 2013 Financial Results on Thursday, March 13, 2014 9:31 a.m. March 6, 2014 - BusinessWire - BZX
Idera to Present at the Cowen & Co. 34th Annual Health Care Conference 9:31 a.m. Feb. 26, 2014 - BusinessWire - BZX
Idera to Present at the 2014 RBC Capital Markets’ Global Healthcare Conference 5:02 p.m. Feb. 18, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 5:15 p.m. Feb. 10, 2014 - BusinessWire - BZX
Idera to Present at 16th Annual BIO CEO & Investor Conference 9:30 a.m. Feb. 6, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stockand Pre-Funded Warrants 10:10 a.m. Feb. 5, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Public Offering of Common Stock and Pre-Funded Warrants 5:01 p.m. Feb. 4, 2014 - BusinessWire - BZX
Idera Announces Publication of New Data Demonstrating Impact of Inhibiting TLRs 7, 8, and 9 in a Preclinical Model of Autoimmune Disease 9:01 a.m. Jan. 22, 2014 - BusinessWire - BZX
Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine 9:00 a.m. Jan. 9, 2014 - PR Newswire
Idera Expands Leadership Team and Strengthens Clinical Development Expertise in Oncology and Orphan Diseases 9:00 a.m. Jan. 9, 2014 - BusinessWire
Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera 9:00 a.m. Dec. 31, 2013 - PR Newswire
Senior Appointments, Stock Splits, New Guidelines, Positive Results, and Clinical Trial Updates - Research Report on Receptos, MEDNAX, CombiMatrix, Anacor, and Idera 9:00 a.m. Dec. 10, 2013 - PR Newswire
Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenstrom's Macroglobulinemia 8:30 a.m. Dec. 4, 2013 - BusinessWire
Idera Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 5:02 p.m. Nov. 25, 2013 - BusinessWire
Idera Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Corporate Update 8:45 a.m. Nov. 14, 2013 - BusinessWire
Idera Pharmaceuticals to Host Conference Call to Report Third Quarter 2013 Financial Results on Thursday, November 14, 2013 5:10 p.m. Nov. 7, 2013 - BusinessWire
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 4:14 p.m. Sept. 30, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...